Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • CATAPRESAN ® - Healthy
    Clinical Study Number 253.2486
    Study Indication Healthy
    Product CATAPRESAN ®
    Generic Name Clonidine
    Lab Code
    Clinical Phase I
    Study Title

    A randomised, double-blind study designed to assess the bioequivalence and adhesion properties of transdermal clonidine-VistanexTM compared to transdermal clonidine-Oppanol® following transdermal administration in healthy male and female volunteers

    Study Document
    Trial synopsis 253.2486 english